NONMEM in drug development -Reply

From: Chiangs Date: July 11, 1996 technical Source: cognigencorp.com
From ChiangS@war.wyeth.com Thu Jul 11 09:16:04 1996 Subject: NONMEM in drug development -Reply Hi: While I can not offer an example to meet the challenge by that "top-consultant", I have noted something might be of interest to both of you. At the recent FDLI workshop in D.C., June 17-18, Bob Temple recommended as a pivotal study a dose-titration study in a "good population" coupled with NONMEM analysis. You might want to ask Temple if he thinks NONMEM analysis would make a difference big enough to satisfy your challenger. Temple said as far as he knows there is no such study has been submitted. SC.
Jul 04, 1996 Rik Schoemaker NONMEM in drug development
Jul 04, 1996 Nick Holford Re: NONMEM in drug development
Jul 05, 1996 Jean Louis Steimer Re: NONMEM in drug development
Jul 08, 1996 Ziadh Re: NONMEM in drug development
Jul 08, 1996 Rik Schoemaker NONMEM in drug development
Jul 09, 1996 Janet Wade NONMEM in drug development
Jul 09, 1996 Ferrin Harrison Utility of NONMEM
Jul 09, 1996 Davide tools and science
Jul 11, 1996 Chiangs NONMEM in drug development -Reply
Jul 11, 1996 Nick Holford Re: NONMEM in drug development -Reply